Massive posterior fossa tuberculous abscess developing in a young child treated for miliary tuberculosis: Possible role of very rapid acetylation of isoniazid

Pediatric Neurosurgery

Volumn 29, Issue 2, 1998, Pages 64-68

  Schoeman, J F ^a,b   Morkel, A ^a   Seifart, H I ^a   Parkin, D P ^a   Van Helden, P D ^a   Hewlett, R H ^a   Donald, P R ^a  

^a STELLENBOSCH UNIVERSITY   (South Africa)

^b STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

Acetylation, isoniazid; Isoniazid; Magnetic resonance imaging; Miliary tuberculosis; Surgery; Tuberculous abscess

Indexed keywords

ISONIAZID; PYRAZINAMIDE; RIFAMPICIN;

ABSCESS DRAINAGE; ACETYLATOR PHENOTYPE; ARTICLE; BRAIN ABSCESS; BRAIN VENTRICLE PERITONEUM SHUNT; CASE REPORT; CHILD; DOSE RESPONSE; DRUG ACETYLATION; FEMALE; HUMAN; HYDROCEPHALUS; MILIARY TUBERCULOSIS; POSTERIOR FOSSA; PRIORITY JOURNAL;

EID: 0031738981     PISSN: 10162291     EISSN: None     Source Type: Journal    
DOI: 10.1159/000028691     Document Type: Article

References (16)

1. Henrickson M, Weisse ME: Tuberculous brain abscess in a three-year-old South Pacific Islander. Pediatr Infect Dis J 1992;11:488-491.
2. Afghani B, Lieberman JM: Paradoxical enlargement or development of intracranial tuberculomas during therapy: Case report and review. Clin Infect Dis 1994;19:1092-1099.
3. Tang ESC, Chau A, Fong D, Humphries MJ: The treatment of multiple tuberculous brain abscesses: A case report. J Neurol 1991;238:183-185.
4. Seifart HI, Gent WL, Parkin DP, van Jaarsveld PP, Donald PR: High-performance liquid chromatographic determination of isoniazid, acetylisoniazid and hydrazine in biological fluids. J Chromatogr B Biomed Appl 1995;674:269-275.
5. Parkin DP, Vandenplas S, Botha FJH, Vandenplas ML, Seifart HI, van Helden PD, van der Walt BJ, Donald PR, van Jaarsveld PP: Trimodality of isoniazid elimination. Phenotype and genotype in patients with tuberculosis. Am J Respir Crit Care Med 1997;155: 1717-1722.
6. Chambers ST, Record C, Hendrickse WA, Rudge P: Paradoxical expansion of intracranial tuberculoma during chemotherapy. Lancet 1984;ii:181-183.
7. Schoeman JF, Van Zyl LE, Laubscher JA, Donald PR: Effect of corticosteroids on intracranial pressure, computed tomographic findings, and clinical outcome in young children with tuberculous meningitis. Pediatrics 1996;99:226-231.
8. Prakash B, Metha G, Gondal R, Kumar S, Malhorra V: Tuberculous abscess of the brain stem. Surg Neural 1989;32:445-448.
9. Elliot AM, Berning SE, Iseman MD, Peloquin CA: Failure of drug penetration and acquisition of drug resistance in chronic tuberculous empyema. Tuber Lung Dis 1995;76:463-467.
10. Mandel W, Cohn ML, Russel WF Jr, Middlebrook G: Serum isoniazid levels and catalase activities of tubercle bacilli from isoniazid-treated patients. Am J Med Sci 1957;233:66.
11. Beggs WH, Jenne JW: Isoniazid uptake and growth inhibition of Mycobacterium tuberculosis in relation to time and concentration of pulsed drug exposures. Tubercle 1969;50:377-385.
12. Ellard GA: The potential clinical significance of the isoniazid acetylator phenotype in the treatment of pulmonary tuberculosis. Tubercle 1984;65:211-227.
13. Mandell GL, Petri WA: Antimicrobial agents; in Hardman JG, Limbird LE, Molin Zoff PB, Ruddon RW, Gilman AG, (eds): The Pharmacological Basis of Therapeutics, ed 9. New York, McGraw Hill, 1996, p 1750.
14. Gibaldi M, Perrier D: Pharmacokinetics, ed 2. New York, Dekker, 1982, p 15.
15. Schoeman JF, Van Zyl LE, Laubscher JA, Donald PR: Serial CT scanning in childhood tuberculous meningitis: Prognostic features in 198 cases. J Child Neurol 1995;10:320-329.
16. Rook GAW, Al Attiyah R: Cytokines and the Koch phenomenon. Tubercle 1991;72:13-20.